CASP3 and glioblastoma: We did not observe marked increases in cleaved caspase 3 following GRHL2 induction in LN229 cells (Figure 2A,B,E), indicating that reprogramming GBM cells with GRHL2 is not sufficient to drive appreciable apoptosis.